Takeda launches “Spot Lymphoma, Stop Lymphoma” initiative

Biopharmaceutical leader Takeda Healthcare Philippines Inc. (“Takeda Philippines”) has launched the “Spot Lymphoma, Stop Lymphoma” initiative to answer the call of the government’s National Integrated Cancer Control Act for medical stakeholders to come together and work towards a cancer-free Philippines. 

The initiative is led by Takeda Philippines and is supported by various organizations including the Philippine Cancer Society, Health Futures Inc., Philippine College of Hematology and Transfusion Medicine, Philippine Society of Hematology and Blood Transfusion, Philippine Society of Medical Oncology, Philippine Society of Pathologists, Carewell Community Foundation and Lymphoma Philippines. “Spot Lymphoma, Stop Lymphoma” aims to raise awareness about lymphoma and improve access to lymphoma treatments in the Philippines by providing free testing to patients, partnering with relevant organizations and institutions, and sponsoring talks and seminars to educate the public about the disease.